A simple blood draw could spot colorectal cancer early

NCT ID NCT07035691

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study is testing whether a blood test can accurately identify colorectal cancer or polyps in adults referred for suspected lower GI cancer. Participants provide a blood sample during their routine diagnostic visit, and their results are compared to their final diagnosis. The study also explores patient preferences for blood-based tests versus more invasive procedures like colonoscopy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A blood test measuring progastrin (hPG80) and transposable elements (TEs)
What this could lead to
If accurate, this blood test could offer a less invasive way to detect colorectal cancer and polyps, potentially reducing the need for colonoscopies.
What could go wrong
This is an observational study, so it won't prove the test works in practice. The biomarkers may not be accurate enough, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barts Health NHS Trust

    RECRUITING

    London, England, E1 2AT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.